The week of 2026-03-31, 2 companies reported a bankruptcy or receivership to the SEC on Form 8-K under Item 1.03. Open a company for the filing's own words on the petition, chapter, court and case.
| Filed | Company | Chapter | State | Industry | Filing |
|---|---|---|---|---|---|
| 2026-03-31 | IO Biotech, Inc. | Chapter 7 | G7 | Pharmaceutical Preparations | SEC filing |
| 2026-03-31 | LIPELLA PHARMACEUTICALS INC. | Chapter 11 | SEC filing |
In the filings' own words
IO Biotech, Inc., 2026-03-31
On March 31, 2026, after considering all strategic alternatives, IO Biotech, Inc. (the "Company") ceased operations and filed a voluntary petition for relief (the "Petition") under the provisions of Chapter 7 of Title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court").
LIPELLA PHARMACEUTICALS INC., 2026-03-31
On [Filing Date] , [Company Name, Inc.] (the "Company") and certain of its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Western District of Pennsylvania (the "Bankruptcy Court").
Where this comes from
Public companies report a bankruptcy, a receivership or a similar proceeding to the SEC on Form 8-K under Item 1.03, usually within four business days. Every filing listed here is one of them, linked to the filing itself. The sentences shown are quoted from the filing exactly; where a filing does not state the court, the case or the chapter in one sentence, nothing is shown in its place.
The state is where the company says its business is, and the industry is the one it registered with the SEC. A filing reports what the company filed; it does not say whether creditors will be paid, and neither does this page.
All recent bankruptcy filingsPrevious weekNext week
Cite this page
https://mentionfox.com/bankruptcy/week/2026-14